A bill to amend the Federal Food, Drug, and Cosmetic Act to require country of origin labeling on prescription and over-the-counter drugs.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Senator for Ohio. Democrat.
Last Updated: Sep 26, 2008
Length: 3 pages
110th Congress, 2007–2009
This bill was introduced on September 26, 2008, in a previous session of Congress, but was not enacted.
Sep 26, 2008
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
S. 3633 (110th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 110th Congress, which met from Jan 4, 2007 to Jan 3, 2009. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2019). S. 3633 — 110th Congress: Transparency in Drug Labeling Act. Retrieved from https://www.govtrack.us/congress/bills/110/s3633
“S. 3633 — 110th Congress: Transparency in Drug Labeling Act.” www.GovTrack.us. 2008. August 18, 2019 <https://www.govtrack.us/congress/bills/110/s3633>
Transparency in Drug Labeling Act, S. 3633, 110th Cong. (2008).
|title=S. 3633 (110th)
|accessdate=August 18, 2019
|author=110th Congress (2008)
|date=September 26, 2008
|quote=Transparency in Drug Labeling Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.